These authors contributed equally to this work.
Introduction
In 2016, over 5 million reconstructive procedures were performed in the United States due to surgical excision of tumors, accidents, and congenital malformations (1) . The need to replace "like with like" guides the reconstructive surgeons in choosing the proper method and means of reconstruction. Therefore, composite defects, consisting of several tissues and their respective mechanical and physiological properties, must ideally be reconstructed with their matching counterparts. The recent success of clinical vascular composite allotransplantation (VCA) attests to the fact that composite tissue allografts have tremendous potential in these life-enhancing reconstructions (2) .
The concept of VCA for restoration of congenital or acquired deformities is not new. In the history of medicine there are several well-documented cases that demonstrate the developing concept of reconstructive transplantation medicine (3) (4) (5) (6) (7) . One such account is "The Legend of the Black Leg (Leggenda Aurea)," about the twins Cosmos and Damian, who transplanted the leg of a man with that of an Ethiopian in 348 AD (8) . In 1957, Peacock et al (8, 9) coined the term "composite tissue allograft" and in 1964, Robert Gilbert (10) performed the first hand transplantation (HTx) in Ecuador. In the 1990s, the advent of more potent immunosuppressants rekindled the interest leading to successful trials in rodents and large animal VCA models (3, 6) . In November 1997, in Louisville, Kentucky the 1st International Symposium on VCA was held. The next two HTx were performed in 1998 by pioneers Dubernard et al (11) (12) (13) in France, and in 1999 by Warren Breidenbach (14) in the United States, thus initiating the modern era of reconstructive HTx (7) . Since 1998 over 100 HTx and 30 face transplants have been reported (15) .
VCA unifies the principles of reconstructive microsurgery and transplant surgery. It achieves the goals of absolute correction of a defect with anatomically and physiologically identical tissue, with none of the issues of donor site morbidity associated with autologous tissue transfer. Nevertheless, its widespread use is hindered by its extreme immunogenicity, severe psychological implications, and graft availability (15, 16) .
VCA is primarily a procedure aimed at improving the recipients' quality of life and psychological well-being. Since candidates considering VCA present no lifethreatening illness, their motivation is gaining improved functional outcomes, occupational attainment, improved body image, and restored touch. Patients must accept a new graft while adapting to their loss of a part of their body that was unique to them (17) . This requires alterations in their sense of self, how the graft fits in with their body image, and ultimately acceptance of the allograft as part of themselves (18) . Better aesthetic match of the graft to the recipient may ameliorate the devastating psychological burden.
As soon as a suitable graft is removed from an organ donor and placed on ice for evaluation, the clock starts ticking and the longer it takes for the organ to reach a recipient the lower the chances for it to be transplanted. Many grafts do not reach the transplantation recipient in time and are discarded without being used due to limitations of delivery distances and reach of the Organ Procurement and Transplantation Network. No data are available for composite allografts, but we can infer from solid organ transplantation data. According to the U.S Department of Health and Human Services, less than 10% of patients' needs for transplantable organs are being met, leading to many patients dying while waiting for a suitable organ for transplantation (7) .
Cryobiologists have long sought to cryopreserve biological samples ranging from single cells to complex organs and whole animals (19) (20) (21) (22) (23) (24) . There are many types of damage that are inflicted on cells and complex tissues during the freezing processes such as (i) cell membrane chilling injury: a loss of membrane elasticity due to lipid phase transition caused by liquid-crystal to crystal-gel form triggered by the temperature reduction (25) (26) (27) , (ii) cell death due to intracellular ice crystals formation (27) , (iii) mechanical damages caused by ice crystals engulfing cells, with tissue and cell rupture due to shearing forces (28, 29) , and (iv) tissue and organ damages due to recrystallization of ice that was melted due to the release of latent heat when first crystallization occurred during cooling (refreezing) and when thawing is performed (recrystallization) (30) . In addition to damages taking place during the freezing process, there are also thawing-related damages. Most of this damage results from recrystallization due to the endothermic process of slow thawing (31). This becomes a major concern when thawing large samples in general and even more so when thawing complex large samples such as large tissues and organs, since the inner part of the sample gets warm at a much slower rate than the exterior part of the sample (32) . To date, successful cryopreservation and thawing of a rat heart model was accomplished (33) . Similarly, a pig liver has been frozen and when thawed resumed bile production (34) . Whole sheep ovaries that were frozen/thawed and then retransplanted back to the ewes resumed hormonal function as well as oocyte production (35, 36) . However, freezing and reimplantation of a whole limb has not yet been done due to the aforementioned complexities.
Directional freezing (DF) is an advanced method for the freezing of biological samples. In this method after the initial seeding stage (in which ice crystals formation is induced), the sample is advanced at a constant velocity through a linear temperature gradient enabling precise control over the freezing process (32, 33) . Vitrification is an alternative cryopreservation method in which the sample solidifies without the formation of ice crystals (31) . We therefore tested the hypothesis that using these methods will enable composite tissue-friendly cryopreservation and transplantation.
Finding a reliable, reproducible, and stable way to preserve composite tissue allografts may expand the available number of composite tissues, limbs, and solid organs for transplantation. Expanding the donor pool may, in turn, enable improved HLA and aesthetic matching. Moreover, the whole approach to VCA may shift from few and far apart emergent surgeries to wide-scale, well planned, and controlled elective surgeries.
Materials and Methods

Experimental design
Six rat hindlimbs from three donor rats were harvested.
Tissue samples were taken from the implanted leg when initially harvested (fresh control).
The limbs were cryopreserved for 7-30 days: three limbs using DF and three limbs using vitrification.
Prior to transplantation (immediately after thawing/warming), tissue samples were taken again.
Group A (n = 3 rats) were transplanted with DF limbs, and Group B (n = 3 rats) were transplanted with vitrified limbs.
Both groups underwent hindlimb transplantation, followed by clinical monitoring of the limb consisting of visual and tactile inspection of the tissues by the surgeon while performing the transplantation and immediately postoperatively, with daily visual inspection of the limb.
The animals were randomly assigned to be euthanized on postoperative day (POD) 1, 2, and 3 and tissue samples were taken from the implanted limb.
All tissue samples taken were prepared and studied following standard hematoxylin and eosin staining.
Skin cells (fibroblast-like cells) were grown in culture for 2 weeks.
Animals
Male, %12-week-old, inbred Lewis (RT1 l) rats weighing 250-300 g were used as donors and recipients of limb heterotrophic isotransplantations. All rats were followed after the transplantation daily for signs of suffering and treated accordingly. The rats' behavior following transplantations of a cryopreserved limb was similar to rats transplanted with a fresh limb. All of the procedures using animals were performed under the institutional ethical committee guidelines and approval.
Surgical procedure: limb harvesting
Three rats were used as donors. Anesthesia was induced by inhalation of Isoflorane 2% and oxygen at a flow rate of 5 L/min in an induction cage. Anesthesia was maintained with inhalant 1-2% isoflurane. The donor surgical site was prepared and a skin incision was made around the circumference of the right hindlimb at the level of the inguinal ligament. Beginning laterally, the skin of the upper thigh was mobilized to expose the biceps femoris. The biceps femoris was then leaving a sufficient edge of residual tissue for later repair. The biceps was reflected to expose the sciatic nerve within the stifle fossa. The sciatic nerve was dissected out proximally to the point of emergence from below the gluteus muscle, preserving mesoneural tissue. The sciatic nerve was transected proximally after a tag suture of 10-0 nylon was placed. The femoral vessels were isolated from the inguinal ligament to the level of the epigastric takeoff. All muscle groups were then sharply divided slightly proximal to the level of the midfemur. The femoral vessels were then clamped above the previously placed suture tags and transected. Using a 22-gauge angiocatheter, approximately 5 mL of warm saline 0.9% and 50 U of heparin were manually perfused through the femoral artery, until the venous effluent was clear. The osteotomy was performed at the midfemur. Once detached, the donor limb (graft) was wrapped in moist gauze and underwent either DF or vitrification. The donor animal was euthanized.
Directional freezing procedure
The DF apparatus is based on two brass blocks, which are thermal-conducting masses and can be cooled or warmed to any desired temperature at any cooling or warming rate. The biological material is placed in tight contact between the two blocks. Depending upon the temperature of the blocks, the contact may allow DF by generation of one or more controlled thermal gradients within the object, without the need to move the object itself. The cost of the DF prototype is estimated to be $30-40K and the operation is around $100/limb.
If not mentioned differently, all chemicals were purchased from SigmaAldrich (St. Louis, MO).
The freezing solution was composed of 10% dimethylsulfoxide (DMSO), 10% fetal bovine serum, and 0.5 M Trehalose in M-199 medium (Biological Industries, Beit Haemek, Israel). Five milliliters of the freezing solution was manually perfused during 8 min into the harvested hindlimb. The leg was inserted into a cryobag (CryoStore CS250; Origen Biomedical, Austin, TX) that was filled with the freezing solution. The bag was frozen using a directional freezing device (A.A. Technologies, Tel Aviv, Israel) ( Figure 1A-C) . Seeding was performed at À7°C, and the cooling rate was set to 0.5°C/min with a temperature gradient of 0.5°C/cm; freezing has ended when the temperature has reached À70°C. After freezing has ended, the bags were stored at À80°C in a Thermo FormaTM freezer (Thermo Fisher Scientific, Waltham, MA) for 7-30 days.
Thawing procedure
The frozen bag was inserted into a water bath heated to 65°C until the outer frozen layer is thawed while the leg inside is still frozen (about 2-3 min). The bag was then opened and the frozen leg was taken out and inserted into 50 mL of M-199 (Biological Industries) supplemented with 1 M sucrose warmed to 38°C. After the leg was completely thawed, it was manually perfused again with 3 mL of M-199 (Biological Industries) with 0.5 M sucrose for 5 min.
Vitrification procedure
The harvested leg was manually perfused during 2 min with each of the following solutions:
(1) 2 mL of 1.6% DMSO, 1.6% ethylene glycol (EG) After perfusion ended, the leg was inserted into an empty cryobag (CryoStore CS250; Origen Biomedical) that was heat sealed with minimal air in it. The bag was then inserted into LN slush (À208°C) using the VitMaster device (IMT, Nes-Ziona, Israel). The bag was then stored in a LN Dewar for 7-30 days.
Warming procedure
The bag was taken out of the LN Dewar and held in the air for 10 s. The bag was then opened and the leg was removed into 50 mL of M-199 (Biological Industries) supplemented with 1 M sucrose warmed to 38°C until the leg is completely warmed.
The leg was then perfused manually during 5 min with the following solutions:
(1) 3 mL of 1 M sucrose in M-199 (Biological Industries). 
Surgical procedure: transplant
Six rats were used as recipients. The animal was anesthetized and prepared for surgery. An oblique incision, approximately 1.5 cm in length, was made on the hip, slightly superior to the leg with exposure and division of the femoral vessels occurring further distally to preserve adequate length for approximation with the donor limb. The donor limb was transplanted by performing vascular anastomoses with simple interrupted sutures of 10-0 nylon. Muscle groups were approximated to the abdominal wall and with 6-0 Prolene. Lactated Ringer's solution (5 mL, IP) was administered. The skin was closed with interrupted 4-0 nylon sutures.
Preparation of skin cultures
Rat thigh skin was removed under sterile conditions from limbs that were frozen by either DF or vitrification, stored under À80 for 7-30 days, and thawed/warmed. Tissue was washed with phosphate-buffered saline to remove excess blood cells. Skin was minced into small fragments and cells were isolated by trypsin-ethylenediamine tetraacetic acid (EDTA) solution (0.25% trypsin-EDTA). Digestion was repeated three times at room temperature, at gentle stirring for 30 min. Digested skin was centrifuged at 300g and cell pellet was seeded on gelatin-coated tissue culture plates. Skin cells were cultured in Dulbecco modified Eagle medium + 10% fetal calf serum + gentamicin (25 lg/mL) in a humidified atmosphere of 5% CO 2 -95% air at 37°C. Medium was changed every 3 days.
Sample treatment
Limbs were stored at À80°C in a Thermo Forma TM freezer (Thermo Fisher Scientific) for 7-30 days. Samples were taken immediately prior to transplantation or following the animals' euthanizing, in order to avoid triggering limb autophagia and to minimize unnecessary suffering.
Results
Six recipient rats (male, Lewis, %12 weeks old) each received a single frozen/thawed or vitrified/warmed hindlimb transplantation from three donor rats (male, Lewis, 12 weeks old) (Figure 2A ).
At the time of transplantation, thawed or warmed vessel integrity, color, and pliability were indistinguishable from the fresh recipient vessels (Figure 3 ). Anastomosis proceeded without difficulty with distal perfusion established as demonstrated by both color ( Figure 2B ) and punctate bleeding of the toes (Figure 2C-D) .
All limbs survived until planned extraction. On daily inspection, edema was most significant at POD 1 and started resolving toward POD 3, as expected. No signs of ischemia were noted. At the time of planned extraction (POD 1, 2, and 3), bleeding was noted from the transplanted limb, most evident in vessels anastomosed and muscles, which seemed viable.
On histology of freshly thawed/warmed, prior to transplantation, limbs had viable muscle, skin, and blood vessels as can be concluded from preservation of histological structure, nuclei, and uniform cell size (Figure 4 ).
On histological study at POD 1, 2, and 3, both limbs that were frozen and limbs that were vitrified had viable muscle, skin, and blood vessels as can be concluded from preservation of histological structure, nuclei, uniform cell size, and no evidence of extreme inflammation as would be expected in response to necrosis ( Figure 5A-K) .
Skin cells extracted from frozen/thawed or vitrified/ warmed limbs that were cryopreserved were grown successfully in culture (Figure 6A-D) .
Discussion
Cryopreservation of composite tissue may be considered the "holy grail" of transplantation surgery and, to a wider extent, reconstructive surgery. Numerous attempts have been made and a most recent report by Wang et al (37) performed on a rat hindlimb as our own acutely illustrates the challenges and incremental advances of the field. In the report, attempts to transplant limbs above the knee failed immediately due to apparent inability to restore blood flow to the thawed limb. Success was described only in small transplants below the level of the ankle (Syme's amputation). These In contrast to this report (37), we found that composite tissue, comprising a midfemor above-knee amputation, can be cryopreserved using either DF or vitrification. Moreover, at POD 3 the composite vascularized grafts were clinically viable. Histologically, tissue and cells retained structure and normal appearance with no direct or indirect signs of cell death, and culture of cells isolated from the skin of a cryopreserved limb was successful, producing viable fibroblast-like cells. We conclude that rat hindlimbs frozen by DF or vitrified can be transplanted using the same techniques that are applied for fresh rat hindlimb transplantation, enabling further research and development of hindlimb cryopreservation technology using our reproducible animal model.
Our results advance on previous success in DF cryopreservation using noncytotoxic cryoprotectants such as that of whole heart cryopreservation published by Elami et al (34) ; whole liver cryopreservation published by Gavish et al (35) ; and whole ovaries published by Arav et al (36) . In the aforementioned studies, a relatively homogeneous tissue was cryopreserved and after thawing, resumed its dedicated function, demonstrating the safe profile of DF. However, the physical complexity of different tissue and interfaces within a composite graft was not addressed. This complexity of cryogenic properties was tested by choosing a composite tissue structure such as a rat hindlimb composed of muscle, blood vessels, bone, bone marrow, nerve, and connective tissue.
The viability of the fibroblast-like cells in isolated skin of cryopreserved limb further grown in culture is a significant finding in that these cells survived individually the potential physical damage of cell membrane chilling injury (24) (25) (26) and mechanical damages caused by ice crystals (27, 28) . The muscle tissue survived rupture due to shearing forces (29) and cell death due to ice crystallization during cooling (refreezing) and thawing (recrystallization) (34) .
The limitations of our study include the small sample size and relatively short follow-up. These were decisions made to limit the number of animals euthanized in the experiment, given our assumption that we are searching for a large effect. A larger number of animals and longer follow-up might have uncovered further effects of the cryopreservation process, possibly in conjunction, and therefore confounded by normal inflammation and wound healing. The cryopreservation process may affect the immunogenicity of the graft. However, it is still unclear what the effect will be since different outcomes were found when this was evaluated in different studies; in some cases the immunogenicity has decreased, in some it was increased, and in some it was unchanged. Nevertheless, the time required for donor and recipient matching will not be an obstacle anymore once cryobanking is achieved (38) (39) (40) (41) (42) (43) . In conclusion, we have demonstrated the successful cryopreservation followed by transplantation of a rat hindlimb as a research model for composite tissue transplantation. Our findings and model may be used for further research and development of DF and verification as a means of cryopreserving larger composite tissue and whole limbs. It is our belief that this course of research may provide a reliable, reproducible, and stable way to preserve composite tissue allografts. This will pave the way for composite tissue, limb, and even organ "banks," increasing availability for transplantation, and expanding the clinical indications creating a true paradigm shift from few and far apart emergent surgeries to wide-scale, wellplanned, and better-controlled elective surgeries.
